BioAdaptives, Inc. to Expand Nationwide Launch of Pawpa(TM) Regen, a Stem Cell-Based Canine Supplement
BioAdaptives, Inc. announces the nationwide launch of Pawpa(TM) Regen, a stem cell-based canine supplement, by July 2025, marking a significant advancement in holistic pet care solutions.
BioAdaptives, Inc. (OTC Pink: BDPT), a pioneer in nutraceutical and wellness innovation, is set to launch its proprietary canine supplement, Pawpa(TM) Regen, nationwide by the end of July 2025. This supplement, designed to support natural stem cell activation in aging dogs, has demonstrated promising outcomes in early trials, including enhancements in energy, mobility, coat quality, and temperament. CEO James Keener highlighted the product's innovative regenerative approach, which utilizes safe, naturally sourced ingredients. The decision to expand production ahead of the broader e-commerce rollout reflects the strong early feedback and increasing demand for holistic pet care solutions.
The launch of Pawpa(TM) Regen represents a significant milestone in the pet care industry, offering a novel approach to improving the quality of life for aging dogs. For more details, visit https://ibn.fm/Y6PRK.